HYSINGLA Drug Patent Profile
✉ Email this page to a colleague
When do Hysingla patents expire, and what generic alternatives are available?
Hysingla is a drug marketed by Knoa Pharma and is included in one NDA. There are nineteen patents protecting this drug.
The generic ingredient in HYSINGLA is hydrocodone bitartrate. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the hydrocodone bitartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Hysingla
A generic version of HYSINGLA was approved as hydrocodone bitartrate by ALVOGEN on January 21st, 2020.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for HYSINGLA?
- What are the global sales for HYSINGLA?
- What is Average Wholesale Price for HYSINGLA?
Summary for HYSINGLA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for HYSINGLA |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for HYSINGLA |
| DailyMed Link: | HYSINGLA at DailyMed |
US Patents and Regulatory Information for HYSINGLA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Knoa Pharma | HYSINGLA ER | hydrocodone bitartrate | TABLET, EXTENDED RELEASE;ORAL | 206627-004 | Nov 20, 2014 | AB | RX | Yes | No | 9,095,615 | ⤷ Start Trial | Y | ⤷ Start Trial | ||
| Knoa Pharma | HYSINGLA ER | hydrocodone bitartrate | TABLET, EXTENDED RELEASE;ORAL | 206627-006 | Nov 20, 2014 | AB | RX | Yes | No | 11,304,909 | ⤷ Start Trial | ⤷ Start Trial | |||
| Knoa Pharma | HYSINGLA ER | hydrocodone bitartrate | TABLET, EXTENDED RELEASE;ORAL | 206627-003 | Nov 20, 2014 | AB | RX | Yes | No | 9,492,390 | ⤷ Start Trial | ⤷ Start Trial | |||
| Knoa Pharma | HYSINGLA ER | hydrocodone bitartrate | TABLET, EXTENDED RELEASE;ORAL | 206627-002 | Nov 20, 2014 | AB | RX | Yes | No | 9,775,809 | ⤷ Start Trial | Y | ⤷ Start Trial | ||
| Knoa Pharma | HYSINGLA ER | hydrocodone bitartrate | TABLET, EXTENDED RELEASE;ORAL | 206627-005 | Nov 20, 2014 | AB | RX | Yes | No | 9,095,615 | ⤷ Start Trial | Y | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
